Stomach Cancer and Its Homoeopathic Management

Author(s):  
Vaidehi Kumari Gupta ◽  

Like other cancer, Stomach cancer is also a life-threatening disease. It is the result of uncontrolled cell growth in the inner lining of the stomach. The condition is often unrecognizable in the early stages as its symptoms are similar to other diseases like gastritis and ulcer. This article stresses on the different points of stomach cancer & its risk factor, symptomatology, investigation in a concise manner & also emphasizes how Homoeopathy manages in such cases by its holistic approach of treatment. Stomach cancer; Ulcer; Homoeopathy; Helicobacter pylori; Similimum

2006 ◽  
Vol 119 (12) ◽  
pp. 2991-2991 ◽  
Author(s):  
Shinkan Tokudome ◽  
Reza Ghadimi ◽  
Sadao Suzuki ◽  
Akihiro Hosono ◽  
Tsutomu Tanaka ◽  
...  

2016 ◽  
Vol 28 (2) ◽  
pp. 107-115 ◽  
Author(s):  
Ji Hyung Nam ◽  
Chang Won Hong ◽  
Byung Chang Kim ◽  
Aesun Shin ◽  
Kum Hei Ryu ◽  
...  

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
T Albreht

Abstract The speaker will present the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action (JA), which is aiming to develop innovative approaches to advances in cancer control and a Roadmap on Implementation and Sustainability of Cancer Control Actions, identifying areas of relevance to AMR. The issue of AMR is an important issue in view of cancer management. It pertains both to the control of one of the pathogens clearly identified as conducive to cancer - Helicobacter pylori as well as to the issues arising from the vulnerability of the cancer patients in the course of oncological treatment. In the previous JA on Cancer Joint Action on Cancer Control (CanCon), an expert consensus process led to the conclusion that population-based screening for Helicobacter pylori, followed by antibiotic treatment at large scale could trigger AMR, even if it could offset some morbidity due to stomach cancer. It is clear that further research activity is necessary to explore this issue since stomach cancer remains a public health challenge. This is important because of late stage detection, resulting in poor survival. The other important issue is the need to protect cancer patients in treatment and beyond by securing effective antibiotic treatment for infections arising from their condition and/or following their treatment.


2018 ◽  
Vol 18 (2) ◽  
pp. 352-371 ◽  
Author(s):  
Jennifer M. Noto ◽  
Kristie L. Rose ◽  
Amanda J. Hachey ◽  
Alberto G. Delgado ◽  
Judith Romero-Gallo ◽  
...  

2019 ◽  
Vol 47 (6) ◽  
pp. 535-547 ◽  
Author(s):  
I. N. Voynovan ◽  
Yu. V. Embutnieks ◽  
D. V. Mareeva ◽  
S. V. Kolbasnikov ◽  
D. S. Bordin

Russia is a country with a high prevalence of Helicobacter pylori (HP) infection, a high incidence of gastric cancer, and its late diagnosis. HР infection has been recognized as the leading manageable risk factor for gastric cancer. Accurate diagnostic tests must be used to identify and control the effectiveness of HP eradication, and effective schemes must be implemented for HP eradication. The aim of this article was to analyze the latest consensus documents, systematic reviews and meta-analyzes that reflected the role of HP as a risk factor for the development of gastric cancer, as well as measures for the risk reduction. We describe in detail the diagnostic methods for HP infection, provide data on their use in the Russian Federation, and analyze the efficacy of eradication regimens. In all HPinfected individuals, HP leads to chronic inflammation in the gastric mucosa and launches a precancerous cascade (Correa's cascade). The risk of gastric cancer increases with severe atrophy, intestinal metaplasia and dysplasia. Primary prevention of gastric cancer is most effective if the eradication is performed before atrophic gastritis develops. The available consensus documents underline the importance of HP infection identification by accurate diagnostics at this stage of chronic gastritis. In Russia, the primary HP diagnosis is based on histology (37.7%), rapid urease test (29.2%), and serology (29.7%). HP stool antigen test (31.3%), 13C-urea breath test (23.4%) and the histological method (23.3%) are most often used to control eradication. Currently, the first line of eradication therapy is recommended as triple therapy with clarithromycin prescribed for 14 days. It is recommended to use double dose of proton pump inhibitors and bismuth to increase the effectiveness of this scheme. A 14-days triple regimen enhanced by bismuth has been recommended as the first-line therapy in the Russian Federation.


Placenta ◽  
2013 ◽  
Vol 34 (9) ◽  
pp. A37-A38 ◽  
Author(s):  
Simona Cardaropoli ◽  
Annalisa Piazzese ◽  
Ettore Piccoli ◽  
Alessandro Rolfo ◽  
Tullia Todros

Author(s):  
Amit Kumar Tyagi

Having/living convenient life through smart devices, people are more interested or more dependent on to predict something for future (i.e., with respect to their health, business, etc.). For that, many prediction models by several researchers are being used in many applications. Due to a vast (rapid) change in lifestyle, people are more prone to a number of life-threatening diseases when it comes to their well-being. Many of these diseases start developing their symptoms in their early stages. But, still many of these diseases like cancer, kidney damages remain unidentified in their developing stages. The earlier a disease is predicted, the easier it becomes to cure it and even prevent it. Predictive modeling provides a huge step forward in medical science in preventing the risk among patients. Prediction modeling is the process of analyzing current conditions to predict future results.


Sign in / Sign up

Export Citation Format

Share Document